Piramal Pharma (BOM:543635) Other Net Income (Loss) : ₹-0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Other Net Income (Loss)?

Piramal Pharma's Other Net Income (Loss) for the three months ended in Mar. 2024 was ₹-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-0 Mil.

Piramal Pharma's quarterly Other Net Income (Loss) increased from Sep. 2023 (₹-0 Mil) to Dec. 2023 (₹0 Mil) but then declined from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹-0 Mil).

Piramal Pharma's annual Other Net Income (Loss) increased from Mar. 2022 (₹-0 Mil) to Mar. 2023 (₹0 Mil) but then declined from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹-0 Mil).

Piramal Pharma Other Net Income (Loss) Historical Data

The historical data trend for Piramal Pharma's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Other Net Income (Loss) Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Other Net Income (Loss)

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial							-	-	-	-	-

Piramal Pharma Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0 Mil.

Piramal Pharma Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (BOM:543635) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (BOM:543635) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

PPLPHARMA:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (BOM:543635) Headlines

No Headlines